Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2011

01-06-2011

Living post treatment: definitions of those with history and no history of cancer

Authors: Kimberly M. Kelly, Neel Shah, Randi Shedlosky-Shoemaker, Kyle Porter, Doreen Agnese

Published in: Journal of Cancer Survivorship | Issue 2/2011

Login to get access

Abstract

Introduction: Breast cancer is the leading cause of cancer, and the second leading cause of cancer death in women. Due to advances in medicine, the 10 year survival rate is 80%, resulting in a large and growing number of breast cancer survivors. Definitions of cancer survivorship from a number of professional organizations and researchers vary, but the research is scant on the meaning of cancer survivorship to people with and without a prior cancer history. Methods: Two studies were conducted (1) to compare individuals with and without a prior personal cancer diagnosis in terms of those who identified as survivors vs. those who did not identify as survivors and (2) to explore explanations of those with and without a prior personal cancer for the term cancer survivor. In Study 1, individuals were surveyed at cancer-themed community health fairs. In Study 2, women were surveyed at a breast oncology clinic. Results: In Study 1 comparing those with and without a prior cancer diagnosis, prior cancer history was the best predictor of survivorship identity, and only three individuals without a prior cancer history included family and friends as survivors. In Study 2 of those with a personal history, longer time since diagnosis, type of cancer (ductal), and comparative risk (higher) were associated with survivor identity. Conclusion: Completion of treatment was seen as a ‘rite of passage’, and thus, may be seen as a shift from the patient identity, which may have negative connotations, to the positive identity of survivor. Implications: Definitions of survivorship vary considerably, and caution should be used when applying the term to those who have no prior personal cancer diagnosis and to those who have had a more recent cancer diagnosis with a more severe disease course.
Literature
1.
go back to reference American Cancer Society. Cancer facts & figures 2010. Atlanta: American Cancer Society; 2010. American Cancer Society. Cancer facts & figures 2010. Atlanta: American Cancer Society; 2010.
2.
go back to reference Institute of Medicine and National Research Council of the National Academies. In: Hewitt M, Ganz PA, editors. From cancer patient to cancer survivor: lost in transition. Washington: The National Academies Press; 2006. Institute of Medicine and National Research Council of the National Academies. In: Hewitt M, Ganz PA, editors. From cancer patient to cancer survivor: lost in transition. Washington: The National Academies Press; 2006.
3.
go back to reference Leigh S. Cancer survivorship: a consumer movement. Semin Oncol. 1994;21(6):783–6.PubMed Leigh S. Cancer survivorship: a consumer movement. Semin Oncol. 1994;21(6):783–6.PubMed
4.
go back to reference Ganz PA, editor. Cancer survivorship: today and tomorrow. New York: Springer; 2007. Ganz PA, editor. Cancer survivorship: today and tomorrow. New York: Springer; 2007.
5.
go back to reference Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313(4):270–3.PubMedCrossRef Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313(4):270–3.PubMedCrossRef
6.
7.
go back to reference Leighl N, Gattellari M, Butow P, et al. Discussing adjuvant cancer therapy. J Clin Oncol. 2001;19(6):1768–78.PubMed Leighl N, Gattellari M, Butow P, et al. Discussing adjuvant cancer therapy. J Clin Oncol. 2001;19(6):1768–78.PubMed
8.
go back to reference Leigh S, Logan C. The cancer survivorship movement. Cancer Investig. 1991;9(5):571–9.CrossRef Leigh S, Logan C. The cancer survivorship movement. Cancer Investig. 1991;9(5):571–9.CrossRef
9.
go back to reference Vivar CG, McQueen A. Informational and emotional needs of long-term survivors of breast cancer. J Adv Nurs. 2005;51(5):520–8.PubMedCrossRef Vivar CG, McQueen A. Informational and emotional needs of long-term survivors of breast cancer. J Adv Nurs. 2005;51(5):520–8.PubMedCrossRef
10.
go back to reference Clark EJ, Stovall EL. Advocacy: the cornerstone of cancer survivorship. Cancer Pract. 1996;4(5):239–44.PubMed Clark EJ, Stovall EL. Advocacy: the cornerstone of cancer survivorship. Cancer Pract. 1996;4(5):239–44.PubMed
11.
12.
go back to reference Welch-McCaffrey D, Hoffman B, Leigh SA, Loescher LJ, Meyskens Jr FL. Surviving adult cancers. Part 2: Psychosocial implications. Ann Intern Med. 1989;111(6):517–24.PubMed Welch-McCaffrey D, Hoffman B, Leigh SA, Loescher LJ, Meyskens Jr FL. Surviving adult cancers. Part 2: Psychosocial implications. Ann Intern Med. 1989;111(6):517–24.PubMed
13.
go back to reference Twombly R. What's in a name: who is a cancer survivor? J Natl Cancer Inst. 2004;96(19):1414–5.PubMed Twombly R. What's in a name: who is a cancer survivor? J Natl Cancer Inst. 2004;96(19):1414–5.PubMed
14.
go back to reference Feuerstein, M. Defining cancer survivorship. J Cancer Surviv. 2007; 1 (1):5-7.CrossRef Feuerstein, M. Defining cancer survivorship. J Cancer Surviv. 2007; 1 (1):5-7.CrossRef
15.
go back to reference Bellizzi KM, Blank TO. Cancer-related identity and positive affect in survivors of prostate cancer. J Cancer Surviv. 2007;1(1):44–8.PubMedCrossRef Bellizzi KM, Blank TO. Cancer-related identity and positive affect in survivors of prostate cancer. J Cancer Surviv. 2007;1(1):44–8.PubMedCrossRef
16.
go back to reference Deimling GT, Kahana B, Schumacher J. Life threatening illness and identity: the transition from victim to survivor. J Aging Ident. 1997;2(3):165–86. Deimling GT, Kahana B, Schumacher J. Life threatening illness and identity: the transition from victim to survivor. J Aging Ident. 1997;2(3):165–86.
17.
go back to reference Deimling GT, Bowman KF, Wagner LJ. Cancer survivorship and identity among long-term survivors. Cancer Investig. 2007;25(8):758–65.CrossRef Deimling GT, Bowman KF, Wagner LJ. Cancer survivorship and identity among long-term survivors. Cancer Investig. 2007;25(8):758–65.CrossRef
18.
go back to reference Park CL, Zlateva I, Blank TO. Self-identity after cancer: "survivor", "victim", "patient", and "person with cancer". J Gen Intern Med. 2009;24 Suppl 2:S430–5.PubMedCrossRef Park CL, Zlateva I, Blank TO. Self-identity after cancer: "survivor", "victim", "patient", and "person with cancer". J Gen Intern Med. 2009;24 Suppl 2:S430–5.PubMedCrossRef
19.
go back to reference Kaiser K. The meaning of the survivor identity for women with breast cancer. Soc Sci Med. 2008;67(1):79–87.PubMedCrossRef Kaiser K. The meaning of the survivor identity for women with breast cancer. Soc Sci Med. 2008;67(1):79–87.PubMedCrossRef
20.
go back to reference Little M, Paul K, Jordens CF, Sayers EJ. Survivorship and discourses of identity. Psycho-Oncology. 2002;11(2):170–8.PubMedCrossRef Little M, Paul K, Jordens CF, Sayers EJ. Survivorship and discourses of identity. Psycho-Oncology. 2002;11(2):170–8.PubMedCrossRef
21.
go back to reference Kelly KM, Porter K, Remy A, Westman JA. Promotion of cancer family history awareness: Jameslink cancer risk assessment tool at community health fairs. J Genet Couns. 2008;17(3):274–82.PubMedCrossRef Kelly KM, Porter K, Remy A, Westman JA. Promotion of cancer family history awareness: Jameslink cancer risk assessment tool at community health fairs. J Genet Couns. 2008;17(3):274–82.PubMedCrossRef
23.
go back to reference Katz J. From how to why: on luminous description and causal inference in ethnography (part 1). Ethnography. 2001;2(4):443–73. Katz J. From how to why: on luminous description and causal inference in ethnography (part 1). Ethnography. 2001;2(4):443–73.
24.
go back to reference Borkan J. Immersion/Crystallization. In: Crabtree BF, Miller WL, editors. Doing qualitative research. Thousand Oaks: Sage; 1999. p. 179–94. Borkan J. Immersion/Crystallization. In: Crabtree BF, Miller WL, editors. Doing qualitative research. Thousand Oaks: Sage; 1999. p. 179–94.
25.
go back to reference Merriam SB. Assessing and evaluating qualitative research. In: Merriam SB, editor. Qualitative research in practice: examples for discussion and analysis. San Francisco: Jossey-Bass; 2002. p. 18–33. Merriam SB. Assessing and evaluating qualitative research. In: Merriam SB, editor. Qualitative research in practice: examples for discussion and analysis. San Francisco: Jossey-Bass; 2002. p. 18–33.
26.
go back to reference Geertz C. The interpretation of cultures: selected essays. New York: Basic Books; 1973. Geertz C. The interpretation of cultures: selected essays. New York: Basic Books; 1973.
27.
go back to reference Case DO, Johnson D, Andrews JE, Allard SL, Kelly KM. From two-step flow to the internet: the changing array of sources for genetics information seeking. J Am Soc Inform Sci Tech. 2004;55(8):660–9.CrossRef Case DO, Johnson D, Andrews JE, Allard SL, Kelly KM. From two-step flow to the internet: the changing array of sources for genetics information seeking. J Am Soc Inform Sci Tech. 2004;55(8):660–9.CrossRef
28.
go back to reference Kelly KM, Andrews JE, Case DO, Allard SL, Johnson JD. Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians. J Rural Health. 2007;23(2):166–72.PubMedCrossRef Kelly KM, Andrews JE, Case DO, Allard SL, Johnson JD. Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians. J Rural Health. 2007;23(2):166–72.PubMedCrossRef
29.
go back to reference Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 1994;16:171–6.PubMed Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr. 1994;16:171–6.PubMed
30.
go back to reference Kelly K, Leventhal H, Andrykowski M, et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho-Oncology. 2005;14(1):34–48.PubMedCrossRef Kelly K, Leventhal H, Andrykowski M, et al. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psycho-Oncology. 2005;14(1):34–48.PubMedCrossRef
31.
go back to reference Leventhal H, Benyamini Y, Brownlee S, et al. Illness representation: theoretical foundations. In: Petrie KJ, Weinman JA, editors. Perceptions of health and illness. London: Harwood; 1997. p. 19–45. Leventhal H, Benyamini Y, Brownlee S, et al. Illness representation: theoretical foundations. In: Petrie KJ, Weinman JA, editors. Perceptions of health and illness. London: Harwood; 1997. p. 19–45.
32.
go back to reference Charmaz K. Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn. 1983;5(2):168–95.PubMedCrossRef Charmaz K. Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn. 1983;5(2):168–95.PubMedCrossRef
33.
go back to reference Goffman E. The presentation of self in everyday life. New York: Anchor Books; 1959. Goffman E. The presentation of self in everyday life. New York: Anchor Books; 1959.
34.
go back to reference Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon & Schuster; 1963. Goffman E. Stigma: notes on the management of spoiled identity. New York: Simon & Schuster; 1963.
Metadata
Title
Living post treatment: definitions of those with history and no history of cancer
Authors
Kimberly M. Kelly
Neel Shah
Randi Shedlosky-Shoemaker
Kyle Porter
Doreen Agnese
Publication date
01-06-2011
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2011
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0167-1

Other articles of this Issue 2/2011

Journal of Cancer Survivorship 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine